Navigation Links
SafeCode Drug Technologies Corp Signs an Agreement With INTOVISION PRODUCT DEVELOPMENT & DESIGN (An Israeli Product Development Co) to Manufacturers the World's First Voice Recognition Drug Safety Application Prototype
Date:1/17/2013

JERUSALEM, January 17, 2013 /PRNewswire/ --

SafeCode Drug Technologies Corp. (OTCBB: SAFC), a developer of a patent-pending voice recognition technology that reduces the risks of errors during the administration of prescription medications, has signed an agreement with INTOVISION PRODUCT DEVELOPMENT & DESIGN  to manufacturers the world's first voice recognition drug safety application  Prototype.

The development is expected to take 4 months at which time it will be demonstrated to the world's leading drug (and drug container) manufacturers.

A video demonstration of the product applications can be viewed at http://youtube/PEy9ygT6jaA.

SafeCode is the developer of the world's first patent-protected voice recognition technology used to confirm prescription medications prior to their administration at home or in a medical center.  

Using SafeCode technology, prescription medications stored in specially designed locked containers can only be accessed and administered once the caregiver or patient correctly announces the name of the drug.

The technology ensures that the appropriate medication is being administered, as mistakes have accounted for thousands of deaths in recent years.  Often, nurses, doctors or patients are not careful when giving or taking medications and much medication's packaging may look similar. SafeCode Technology prevents medication errors, and thereby reduces the risk of severe injury or accidental death.

"We are hopeful that a contract with a manufacturer will be signed in the coming weeks, enabling us to build our first product prototype," said Joel Klopfer , Chief Executive Officer of SafeCode Drug Technologies.  "There is a large addressable market for this technology due to the thousands of deaths each year related to medication errors."

About SafeCode Drug Technologies

SafeCode Drug Technologies is the developer of a patent-pending voice recognition technology that provides an essential degree of security that can effectively prevent unauthorized administration of a prescription medication.  

Forward-Looking Statements

This letter contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities Exchange Act of 1934 as amended. All forward-looking statements are inherently uncertain, based on current expectations and assumptions concerning future events or future performance of SafeCode Drug Technologies Corp., and its technologies. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release, as actual results may differ materially from those indicated.  SafeCode Drug Technologies Corp. public filings may be viewed at http://www.sec.gov.

Contact:
Joel Klopfer
Joel.Klofer1@gmail.com
+9722-5021322



'/>"/>
SOURCE Safecode Drug Technologies Corp.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. SafeCode Drug Technologies Corporation Identifies the Technology Group to Commence and Develop the Worlds First Prototype for its Next Generation Application for Drug Safety Administration
2. SafeCode Drug Technologies Launches New Website With Product Video Demonstrating the Worlds Next Generation Application for Drug Safety Administration
3. SafeCode Drug Technologies Corp. in Negotiations With Manufacturers to Develop Prototype
4. SafeCode Drug Technologies Corp. Begins Trading on the Over-the-Counter Bulletin Board
5. UV Flu Technologies Outlines Distribution and Expansion Plans for 2013
6. Cumberland Emerging Technologies Expands Life Sciences Center
7. Blue Belt Technologies annonce que le Golden Jubilee National Hospital a réalisé la première opération NavioPFS darthroplastie unicondylaire du genou
8. Blue Belt Technologies Announces Golden Jubilee National Hospital Completes Initial NavioPFS Unicondylar Knee Replacement Surgery
9. Abuse Deterrent Medicines Developer Pisgah Laboratories, Inc. Wins Top 5 Technologies Award from CLAAD
10. OrthoAccel Technologies, Inc. Announces Appointment of New Chief Financial Officer
11. Innovative CA Tumor Marker Tests Technologies and Emerging Markets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... Mederi Therapeutics Inc . anunciou aprovação regulatória, pela CFDA, e lançamento de produto ... gastroesofágico (DRGE). Foto -  http://photos.prnewswire.com/prnh/20161207/446903 ... ... performed and broadcast during the Chinese Congress of Digestive Endoscopy, by Professor Jun ... , , ...
(Date:12/8/2016)... LAVAL, Quebec , Dec. 8, 2016 /PRNewswire/ ... and TSX: VRX) ("Valeant") today announced positive ... vehicle-controlled clinical study to assess the safety and ... in the treatment of plaque psoriasis. ... adult subjects with moderate to severe psoriasis, IDP-118 ...
(Date:12/8/2016)... 2016 Information products and services provider ... Scopus , the world,s largest abstract and citation database of ... for journals from over 5,000 publishers. The new set of metrics ... to and when to adjust a journal,s editorial strategy. ... , , ...
Breaking Medicine Technology:
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... technologies and development solutions for drugs, biologics and consumer health products, today announced ... was set up in 2006 as a non-profit organization to unite pharmaceutical and ...
(Date:12/8/2016)... Charlotte, NC (PRWEB) , ... December 08, 2016 ... ... repeal Medicare and the Affordable Care Act. Dr. Botelho advocates for the mass ... A story movement gives people ongoing opportunities to share their unfortunate experiences; such ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... serve communities in and around the greater Phoenix metropolitan region, is announcing a ... , The mission of the Homeless Youth Connection is to promote community awareness ...
(Date:12/7/2016)... ... December 07, 2016 , ... DrugDev again demonstrated its dedication ... one of the early adopters completing EU-U.S. Privacy Shield Certification from the U.S. Department ... on both sides of the Atlantic with a mechanism to comply with EU data ...
(Date:12/7/2016)... ... December 07, 2016 , ... Silhouette Instalift is a simple, ... and tightening the skin of the face to create more youthful features. While ... very little downtime, Silhouette Instalift is a novel, minimally invasive facial procedure that ...
Breaking Medicine News(10 mins):